How many insider trades does FilingIQ track for SEER?

FilingIQ tracks 172 Form 4 insider transactions for SEER (Seer, Inc.), covering filings from Dec 3, 2020 onwards. 4 of those were filed in the last 90 days.

Are SEER insiders net buyers or net sellers?

Across the full Form 4 history for SEER, 11 transactions (6%) were open-market purchases and 64 (37%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does SEER insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is SEER in?

Seer, Inc. (SEER) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $112.22M.

SEER insider trading

Healthcare

Seer, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

172

Last 90 days

Buys / sells

6% / 37%

Market cap

$112.22M

About Seer, Inc.

Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Company website: seer.bio

SEER insider activity at a glance

FilingIQ has scored 172 insider transactions for SEER since Dec 3, 2020. The most recent filing in our index is dated May 8, 2026.

Across the full history, 11 open-market purchases and 64 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on SEER insider trades is 59.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live SEER trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding SEER

SOFTBANK GROUP CORP.

$8.63M · 0.0% of AUM

Frequently asked

How many insider trades does FilingIQ track for SEER?: FilingIQ tracks 172 Form 4 insider transactions for SEER (Seer, Inc.), covering filings from Dec 3, 2020 onwards. 4 of those were filed in the last 90 days.
Are SEER insiders net buyers or net sellers?: Across the full Form 4 history for SEER, 11 transactions (6%) were open-market purchases and 64 (37%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does SEER insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is SEER in?: Seer, Inc. (SEER) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $112.22M.

Methodology & sources

Every SEER insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.